283 related articles for article (PubMed ID: 20655898)
1. Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice.
Tanaka H; Nagashima T; Shimaya A; Urano Y; Shimokawa T; Shibasaki M
Eur J Pharmacol; 2010 Oct; 645(1-3):185-91. PubMed ID: 20655898
[TBL] [Abstract][Full Text] [Related]
2. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice.
Nagashima T; Shigematsu N; Maruki R; Urano Y; Tanaka H; Shimaya A; Shimokawa T; Shibasaki M
Mol Pharmacol; 2010 Nov; 78(5):961-70. PubMed ID: 20736318
[TBL] [Abstract][Full Text] [Related]
4. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.
Altomonte J; Richter A; Harbaran S; Suriawinata J; Nakae J; Thung SN; Meseck M; Accili D; Dong H
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E718-28. PubMed ID: 12783775
[TBL] [Abstract][Full Text] [Related]
6. Novel FoxO1 inhibitor, JY-2, ameliorates palmitic acid-induced lipotoxicity and gluconeogenesis in a murine model.
Choi HE; Kim Y; Lee HJ; Cheon HG
Eur J Pharmacol; 2021 May; 899():174011. PubMed ID: 33705803
[TBL] [Abstract][Full Text] [Related]
7. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
10. Hepatic NPC1L1 overexpression ameliorates glucose metabolism in diabetic mice via suppression of gluconeogenesis.
Kurano M; Hara M; Satoh H; Tsukamoto K
Metabolism; 2015 May; 64(5):588-96. PubMed ID: 25660144
[TBL] [Abstract][Full Text] [Related]
11. Evodia alkaloids suppress gluconeogenesis and lipogenesis by activating the constitutive androstane receptor.
Yu L; Wang Z; Huang M; Li Y; Zeng K; Lei J; Hu H; Chen B; Lu J; Xie W; Zeng S
Biochim Biophys Acta; 2016 Sep; 1859(9):1100-1111. PubMed ID: 26455953
[TBL] [Abstract][Full Text] [Related]
12. Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.
Altomonte J; Cong L; Harbaran S; Richter A; Xu J; Meseck M; Dong HH
J Clin Invest; 2004 Nov; 114(10):1493-503. PubMed ID: 15546000
[TBL] [Abstract][Full Text] [Related]
13. Type I neuregulin1α is a novel local mediator to suppress hepatic gluconeogenesis in mice.
Arai T; Ono Y; Arimura Y; Sayama K; Suzuki T; Shinjo S; Kanai M; Abe SI; Semba K; Goda N
Sci Rep; 2017 Feb; 7():42959. PubMed ID: 28218289
[TBL] [Abstract][Full Text] [Related]
14. GCN5L1 modulates cross-talk between mitochondria and cell signaling to regulate FoxO1 stability and gluconeogenesis.
Wang L; Scott I; Zhu L; Wu K; Han K; Chen Y; Gucek M; Sack MN
Nat Commun; 2017 Sep; 8(1):523. PubMed ID: 28900165
[TBL] [Abstract][Full Text] [Related]
15. Phenobarbital reduces blood glucose and gluconeogenesis through down-regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression in rats.
Oda H; Okuda Y; Yoshida Y; Kimura N; Kakinuma A
Biochem Biophys Res Commun; 2015 Oct; 466(3):306-11. PubMed ID: 26348778
[TBL] [Abstract][Full Text] [Related]
16. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
[TBL] [Abstract][Full Text] [Related]
17. PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1.
Qu S; Su D; Altomonte J; Kamagate A; He J; Perdomo G; Tse T; Jiang Y; Dong HH
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E421-34. PubMed ID: 16985262
[TBL] [Abstract][Full Text] [Related]
18. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
19. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
[TBL] [Abstract][Full Text] [Related]
20. GSK3β regulates gluconeogenic gene expression through HNF4α and FOXO1.
Sakamaki J; Daitoku H; Kaneko Y; Hagiwara A; Ueno K; Fukamizu A
J Recept Signal Transduct Res; 2012 Apr; 32(2):96-101. PubMed ID: 22384829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
